July 18, 2017 / 9:08 PM / in 5 months

BRIEF-Progenics Pharmaceuticals says received notification of a Paragraph IV certification for certain patents for subcutaneous Relistor

July 18 (Reuters) - Progenics Pharmaceuticals Inc

* Progenics Pharmaceuticals - On July 14 received notification of a Paragraph IV certification for certain patents for subcutaneous Relistor

* Progenics Pharma - Certification resulted from filing by par sterile products of ANDA challenging patents for subcutaneous relistor - SEC Filing

* Progenics Pharma - Co, licensee for relistor, Salix Pharmaceuticals, assessing notification, intend to "vigorously" enforce relistor intellectual property rights Source text: [bit.ly/2to4wA5] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below